.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Mallinckrodt
US Department of Justice
Healthtrust
Johnson and Johnson
QuintilesIMS
Fuji
Chinese Patent Office
Federal Trade Commission

Generated: September 26, 2017

DrugPatentWatch Database Preview

ORUDIS Drug Profile

« Back to Dashboard

What is the patent landscape for Orudis, and what generic Orudis alternatives are available?

Orudis is a drug marketed by Wyeth Ayerst and Wyeth Cons and is included in two NDAs.

The generic ingredient in ORUDIS is ketoprofen. There are twenty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

Summary for Tradename: ORUDIS

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list97
Clinical Trials: see list1
Patent Applications: see list6,682
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORUDIS at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-001Jul 31, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Cons
ORUDIS KT
ketoprofen
TABLET;ORAL020429-001Oct 6, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-003Jan 9, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ORUDIS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-001Jul 31, 1987► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-003Jan 9, 1986► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Boehringer Ingelheim
Merck
Fuji
US Department of Justice
UBS
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot